What Researchers Did
Researchers conducted a meta-analysis of seven randomized controlled trials to evaluate the efficacy of oxygen therapy for patients with retinal artery occlusion (RAO).
What They Found
Patients who received oxygen therapy exhibited a 5.61 times higher probability of visual improvement compared to the control group (OR = 5.61; 95% CI, 3.60-8.73). Specifically, 100% oxygen and hyperbaric oxygen significantly improved visual acuity, with better effects observed when treatment occurred within 3 months and lasted over 9 hours.
What This Means for Canadian Patients
Canadian patients experiencing retinal artery occlusion may see improved visual outcomes with oxygen therapy, especially when treated with 100% hyperbaric oxygen for more than nine hours. Early intervention within three months of onset appears to be crucial for maximizing visual benefits.
Canadian Relevance
This study did not include any Canadian participants or research sites, so its direct relevance to the Canadian healthcare context is not explicitly established.
Study Limitations
The meta-analysis may be limited by the quality and potential heterogeneity of the included randomized controlled trials.